Assessment of influence of levosimendan on the process of reverse heart remodelling in patients with dilated cardiomyopathy and implanted CRT

被引:0
|
作者
Marchenko, R. Roman [1 ]
Durmanov, S. [1 ]
Kozlov, A. [1 ]
Makarova, N. [1 ]
Bazilev, V. [1 ]
Popilkova, O. [1 ]
机构
[1] Fed Hosp Cardiovasc Surg, Penza, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1517
引用
收藏
页码:322 / 322
页数:1
相关论文
共 50 条
  • [1] Left atrial reverse remodelling in dilated cardiomyopathy
    Nuzzi, Vincenzo
    Raafs, Anne
    Manca, Paolo
    Henkens, Michiel T. h. M.
    Gregorio, Caterina
    Boscutti, Andrea
    Verdonschot, Job
    Hazebroek, Mark
    Knackstedt, Christian
    Merlo, Marco
    Stolfo, Davide
    Sinagra, Gianfranco
    Heymans, Stephane R. B.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [2] Left atrial reverse remodelling in dilated cardiomyopathy
    Nuzzi, Vincenzo
    Raafs, Anne
    Manca, Paolo
    Henkens, Michiel T. H. M.
    Gregorio, Caterina
    Boscutti, Andrea
    Verdonschot, Job
    Hazebroek, Mark
    Knackstedt, Christian
    Merlo, Marco
    Stolfo, Davide
    Sinagra, Gianfranco
    Heymans, Stephane R. B.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [3] Myocardial Fibrosis and Reverse Remodelling in Nonischaemic Dilated Cardiomyopathy
    Barison, Andrea
    Ortalda, Alessandro
    Todiere, Giancarlo
    Vergaro, Giuseppe
    Mirizzi, Gianluca
    Valleggi, Alessandro
    Chiappino, Sara
    Pastormerlo, Luigi Emilio
    Giannoni, Alberto
    Aquaro, Giovanni Donato
    Passino, Claudio
    Emdin, Michele
    CIRCULATION, 2015, 132
  • [4] A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy
    Kimura, Yuki
    Okumura, Takahiro
    Morimoto, Ryota
    Kazama, Shingo
    Shibata, Naoki
    Oishi, Hideo
    Araki, Takashi
    Mizutani, Takashi
    Kuwayama, Tasuku
    Hiraiwa, Hiroaki
    Kondo, Toru
    Murohara, Toyoaki
    ESC HEART FAILURE, 2021, 8 (02): : 1359 - 1368
  • [5] Left ventricular reverse remodelling and fibrosis in nonischaemic dilated cardiomyopathy
    Barison, A.
    Ortalda, A.
    Masci, P. G.
    Todiere, G.
    Vergaro, G.
    Mirizzi, G.
    Chiappino, S.
    Aquaro, G. D.
    Passino, C.
    Emdin, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 307 - 308
  • [6] Electrophysiological effects of levosimendan administration in patients with advanced heart failure secondary to ischemic or dilated cardiomyopathy
    Mavrakis, H. E.
    Kanoupakis, E. M.
    Kallergis, E. M.
    Koutalas, E. P.
    Lathourakis, C. E.
    Nyktari, E. G.
    Manios, E. G.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2007, 28 : 44 - 45
  • [7] Electrophysiological effects of levosimendan administration in patients with advanced heart failure secondary to ischemic or dilated cardiomyopathy
    Kanoupakis, E. M.
    Kallergis, E. M.
    Mavrakis, H. E.
    Lyrarakis, G. M.
    Koutalas, E. P.
    Goudis, C.
    Manios, E. G.
    Vardas, P. E.
    EUROPEAN HEART JOURNAL, 2008, 29 : 301 - 301
  • [8] The Effect of Levosimendan Treatment on QT Dispersion in Patients with Dilated Cardiomyopathy
    Ozturk, O.
    Ozturk, U.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (07): : S37 - S37
  • [9] Anti-apoptotic effects of growth hormone are associated with reverse cardiac remodelling in patients with heart failure secondary to idiopathic dilated cardiomyopathy
    Adamopoulos, S
    Parissis, JT
    Karatzas, D
    Paraskevaidis, I
    Livanis, E
    Karavolias, G
    Degiannis, D
    Kremastinos, D
    EUROPEAN HEART JOURNAL, 2004, 25 : 183 - 183
  • [10] Objective and subjective assessment of heart failure symptoms in patients with dilated cardiomyopathy during left ventricle reverse remodeling
    Dziewiecka, E.
    Winiarczyk, M.
    Wisniowska-Smialek, S.
    Karabinowska-Malocha, A.
    Kaciczak, M.
    Robak, J.
    Baranowski, F.
    Rubis, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 226 - 226